The precision medicine company will work with the U.S. Food and Drug Administration to see how secure patient data can be better put to work in the development of oncology treatments.
The alliance, which includes UPMC, University of Pittsburgh and Carnegie Mellon University, will work with Amazon to better harness data for diagnosis, treatment and prevention.
In collaboration with Premier, the company will work with LifeBridge Health, Riverside Health and St. Luke's University Health Network to develop new machine learning algorithms for personalized care.
SNUH serves more than 8,000 cancer patients per year across 16 cancer specialty centres, 10 multidisciplinary cancer treatment centres, and a cancer clinical trials centre.
Finding the best care for a patient can be a constantly moving target. The number of stakeholders, the constant advance of new information and treatment options and the nuanced demands of different payers make for a maze of complexities to navigate.
Yale, Mayo Clinic to use biometric data from wearables to improve drug development for heart failure
Researchers are working with digital therapeutics specialist Biofourmis, using machine learning technology and the Apple Watch to analyze dozens of physiology biomarkers.
The 10-year initiative will focus on workforce development, education and training for next-generation care delivery.
A multi-year agreement with the machine learning company will start with a tool to identify high-risk GI patients, eventially expanding to other high-burden diseases.
Pre-treatment scans were input into a deep-learning model, which analyzed the scans to create an image signature that predicts treatment outcomes.
The pioneering Pennsylvania health system has picked Ryu, who most recently served as its chief medical officer, to replace Dr. David Feinberg, who joined Google in 2018.